Manage Your Liver
Q:

Hepatitis B: Maintaining normal ALT level can prevent lifelong medication treatment

Hepatitis B: Maintaining normal ALT level can prevent lifelong medication treatment
A:

According to the treatment guidelines published by WHO (World Health Organisation) in 2015, antiviral therapy is not recommended for hepatitis B patients with persistently normal ALT levels regardless of age. [1] Some patients may find this strange, why is antiviral treatment not recommended when virus is in their body?

 

This is because normal levels of ALT enzymes indicate that liver cells are not injured, and that there is no inflammation in the liver. So try to think of it the other way round, why would you require any medications when your liver is completely healthy? Rather than focusing on eliminating the virus from the body, the main objectives of treatment for hepatitis B patients should be to maintain a normal ALT level. Only this can guarantee that the liver is not damaged, and prevent liver fibrosis, cirrhosis or liver cancer. Patients should understand that the cause of these chronic diseases is not the virus itself, but the inflammation in the liver.

 

We recently received a blood test report from a YHK user. [2] This user has been using YHK for a number of years for liver protection. The blood test result shows that although the viral count of HBV is high, the ALT liver enzyme level remained normal. Many specialists advised this user not to take antiviral treatment after seeing persistently normal ALT levels results, and only recommended regular check-ups and monitoring. This is an example of the importance of normal ALT level, and also clearly shows that a high level of virus does not necessarily equals more liver damage.

 

Below are the user’s previous liver function test results:

Test Date ALT AST HBV DNA

2012-05-30

41 27

170,000,000 UI/ml

2012-09-10

24 18 -

2013-03-08

14 22

12,600,000 UI/ml

2014-02-14

13 17

588,000,000 UI/ml

2014-08-27

12 18

368,400,000 UI/ml

2015-03-10

12 20

403,200,000 UI/ml

2016-03-12

11 19

25,200,000 UI/ml

 * This user takes 4 YHK tablets per day.

 

 

Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Tags:
Hepatitis BHepatitis B treatmentHepBALTNormalise ALT level
Related Questions
A:
Research and developing our products has always been a big part of our work. Kyotsujigyo has worked with a number of well established organisations and universities in the past, including the University of Sao Paulo, GAIA Age-Management Foundation, The University of Western Ontario, University of Virginia, Yanaihara Research Institute,  Harada Hospital (Japan) and others.    In 2016 Kyotsujigyo has corporate with the National Key Research Institute in Hong K
A:
NASH is inflammation in the liver developed from accumulated fat in the organ, also known as fatty liver. NASH damages liver cells and liver function, which results in elevated ALT liver enzyme level.    As there are no approved treatments for NASH, the standard recommendation for patients is to lose weight only. However this doesn’t work for everyone so if you are struggling to find a way to stop NASH, please read on.   Wha
Hit Questions
A:
Research and developing our products has always been a big part of our work. Kyotsujigyo has worked with a number of well established organisations and universities in the past, including the University of Sao Paulo, GAIA Age-Management Foundation, The University of Western Ontario, University of Virginia, Yanaihara Research Institute,  Harada Hospital (Japan) and others.    In 2016 Kyotsujigyo has corporate with the National Key Research Institute in Hong K
A:
NASH is inflammation in the liver developed from accumulated fat in the organ, also known as fatty liver. NASH damages liver cells and liver function, which results in elevated ALT liver enzyme level.    As there are no approved treatments for NASH, the standard recommendation for patients is to lose weight only. However this doesn’t work for everyone so if you are struggling to find a way to stop NASH, please read on.   Wha
A:
In 2010, some 4.7 million people aged 65 years or older lived with Alzheimer's disease in the US.   Alzheimer’s is a common brain disease that causes progressive brain cell death that happens over a course of time. It will also cause a shrink in brain size as the tissue has progressively fewer nerve cells and connections. Alzheimer’s is thought to be caused by Protein Plaques building up in the brain cells, these Plaques are found between the dying cel
A:
There are between 10 to 15 million patients in the U.S. with NASH, and among these patients, one-fifth to one-fourth are at risk for cirrhosis or chronic liver damage.   The major characteristic of NASH is fat in the liver, along with inflammation and damage. NASH can be severe and can lead to cirrhosis. The number of NASH cirrhosis patients is currently on the rise, and it is predicted (NAFLD & NASH) to be the number 1 cause of liver transplants by 2020. [1] Ther
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Have
Questions?
Sumbit your question
to us for profeessional answers!
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Looking for help? Ask our customer support team!
Contact Us